ImmunityBio, Inc.
DE ˙ DB ˙ US45256X1037
6,13 € ↓ -0,04 (-0,65%)
2026-06-03
AKTIENPREIS
SecurityDE:26CA / ImmunityBio, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership2,944,888 shares
Latest Disclosed Value $ 22,587,291
UBS Group AG reports 47.57% increase in ownership of 26CA / ImmunityBio, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 2,944,888 shares of ImmunityBio, Inc. (DE:26CA) valued at $19,318,465 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 1,995,607 shares of ImmunityBio, Inc.. This represents a change in shares of 47.57% during the quarter. The current value of the position is $18,052,163 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F IMMUNITYBIO COM 45256X103 2,944,888 949,281 47.57 22,587 471.68 0.0034
2026-01-29 2025-12-31 13F IMMUNITYBIO COM 45256X103 1,995,607 315,025 18.74 3,951 -4.43 0.0006
2025-11-13 2025-09-30 13F IMMUNITYBIO COM 45256X103 1,680,582 489,935 41.15 4,134 31.53 0.0006
2025-08-14 2025-06-30 13F IMMUNITYBIO COM 45256X103 1,190,647 -247,769 -17.23 3,143 -27.40 0.0005
2025-05-13 2025-03-31 13F IMMUNITYBIO COM 45256X103 1,438,416 -149,273 -9.40 4,330 6.52 0.0008
2025-02-14 2024-12-31 13F IMMUNITYBIO COM 45256X103 1,587,689 1,181,256 290.64 4,064 168.96 0.0008
2024-11-14 2024-09-30 13F IMMUNITYBIO COM 45256X103 406,433 -51,822 -11.31 1,512 -47.82 0.0003
2024-08-14 2024-06-30 13F IMMUNITYBIO COM 45256X103 458,255 -467,234 -50.49 2,896 -41.72 0.0007
2024-05-13 2024-03-31 13F IMMUNITYBIO COM 45256X103 925,489 882,777 2,066.81 4,970 2,221.96 0.0012
2024-02-09 2023-12-31 13F IMMUNITYBIO COM 45256X103 42,712 2,930 7.37 214 219.40 0.0001
2023-11-09 2023-09-30 13F IMMUNITYBIO COM 45256X103 39,782 70 0.18 67 -39.09 0.0000
2023-08-11 2023-06-30 13F IMMUNITYBIO COM 45256X103 39,712 -74,666 -65.28 110 -47.12 0.0000
2023-05-12 2023-03-31 13F IMMUNITYBIO COM 45256X103 114,378 -254,225 -68.97 208 -88.87 0.0001
2023-02-08 2022-12-31 13F IMMUNITYBIO COM 45256X103 368,603 252,685 217.99 1,869 224.31 0.0007
2022-11-10 2022-09-30 13F IMMUNITYBIO COM 45256X103 115,918 65,845 131.50 576 209.68 0.0003
2022-08-10 2022-06-30 13F IMMUNITYBIO COM 45256X103 50,073 -122,957 -71.06 186 -80.84 0.0001
2022-05-16 2022-03-31 13F IMMUNITYBIO COM 45256X103 173,030 -181,957 -51.26 971 -55.03 0.0003
2022-02-14 2021-12-31 13F IMMUNITYBIO COM 45256X103 354,987 76,288 27.37 2,159 -20.45 0.0006
2021-11-15 2021-09-30 13F IMMUNITYBIO COM 45256X103 278,699 251,520 925.42 2,714 599.48 0.0009
2021-08-13 2021-06-30 13F IMMUNITYBIO COM 45256X103 27,179 -28,835 -51.48 388 -70.83 0.0001
2021-05-12 2021-03-31 13F IMMUNITYBIO COM 45256X103 56,014 50,858 986.38 1,330 1,827.54 0.0004
2021-02-11 2020-12-31 13F NANTKWEST COM 63016Q102 5,156 -5,259 -50.49 69 -4.17 0.0000
2020-11-12 2020-09-30 13F NANTKWEST COM 63016Q102 10,415 -5,297 -33.71 72 -62.69 0.0000
2020-07-31 2020-06-30 13F NANTKWEST COM 63016Q102 15,712 10,162 183.10 193 1,106.25 0.0001
2020-05-01 2020-03-31 13F NANTKWEST COM 63016Q102 5,550 -4,251 -43.37 16 -56.76 0.0000
2020-02-14 2019-12-31 13F NANTKWEST COM 63016Q102 9,801 -4,253 -30.26 37 117.65 0.0000
2019-11-14 2019-09-30 13F NANTKWEST COM 63016Q102 14,054 6,633 89.38 17 112.50 0.0000
2019-08-14 2019-06-30 13F NANTKWEST COM 63016Q102 7,421 -4,814 -39.35 8 -57.89 0.0000
2019-05-14 2019-03-31 13F NANTKWEST COM 63016Q102 12,235 -11,769 -49.03 19 -32.14 0.0000
2019-02-14 2018-12-31 13F NANTKWEST COM 63016Q102 24,004 17,004 242.91 28 7.69 0.0000
2018-11-14 2018-09-30 13F NANTKWEST COM 63016Q102 7,000 -41,523 -85.57 26 -82.55 0.0000
2018-08-14 2018-06-30 13F NANTKWEST COM 63016Q102 48,523 41,523 593.19 149 451.85 0.0001
2018-05-15 2018-03-31 13F NANTKWEST COM 63016Q102 7,000 -5,564 -44.29 27 -51.79 0.0000
2018-02-14 2017-12-31 13F NANTKWEST COM 63016Q102 12,564 1,187 10.43 56 -9.68 0.0000
2017-11-14 2017-09-30 13F NANTKWEST COM 63016Q102 11,377 2,138 23.14 62 -11.43 0.0000
2017-11-14 2017-06-30 13F/A-1 NANTKWEST COM 63016Q102 9,239 1,689 22.37 70 159.26 0.0000
2017-08-14 2017-06-30 13F NANTKWEST COM 63016Q102 9,239 1,689 70
2017-11-14 2017-03-31 13F/A-1 NANTKWEST COM 63016Q102 7,550 5,050 202.00 27 92.86 0.0000
2017-05-12 2017-03-31 13F NANTKWEST COM 63016Q102 7,550 5,050 27
2017-02-14 2016-12-31 13F NANTKWEST COM 63016Q102 2,500 -370 -12.89 14 -39.13 0.0000
2016-11-14 2016-09-30 13F NANTKWEST COM 63016Q102 2,870 670 30.45 23 76.92 0.0000
2016-08-12 2016-06-30 13F NANTKWEST COM 63016Q102 2,200 -700 -24.14 13 -45.83 0.0000
2016-05-12 2016-03-31 13F NANTKWEST COM 63016Q102 2,900 850 41.46 24 -33.33 0.0000
2016-02-16 2015-12-31 13F NANTKWEST COM 63016Q102 2,050 50 2.50 36 56.52 0.0000
2015-11-13 2015-09-30 13F NANTKWEST COM 63016Q102 2,000 2,000 23 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.